Unicornshell
About Us
Unicornshell Focuses on
Plant-Based Pharmaceutical Excipients and Advanced Capsule Technologies

We provide high-performance hypromellose (HPMC) and starch-based capsules to global manufacturers of pharmaceuticals, nutraceuticals, and dietary supplements.

Shanghai Unicornshell Pharmaceutical Technology Co., Ltd. ("Unicornshell") is a technology-driven enterprise dedicated to the R&D, production, and sales of plant-based pharmaceutical excipients and innovative traditional Chinese medicine (TCM) formulations. With the mission of "promoting medication safety and protecting human health", the company strives to become a global pioneer in the intelligent manufacturing of plant-based capsules.
Products
All-Scenario HPMC Capsules Solutions
The company specializes in the R&D of HPMC capsule material technology, offering a range of HPMC capsule product solutions widely used in pharmaceutical preparations, nutraceuticals, and functional foods.
We support capsule color customization, tailored formulations, and printing services.
Core Technology Advantages
Core Technical Advantages
  • Natural HPMC Raw Materials
    Selected high-quality HPMC and plant starch materials, derived purely from plant sources with no animal ingredients, complying with vegetarian, Halal, and Kosher standards, suitable for diverse global cultural markets.
  • Low-Temperature Dipping Technology
    Utilizing a low-temperature dipping process to significantly improve capsule uniformity, transparency, and surface smoothness, resulting in more stable structure and superior batch consistency.
  • High Stability Performance
    Stable moisture content control, non-brittle structure, adaptable to various storage environments; excellent equipment compatibility, with a machine acceptance rate of up to 99.99%.
  • Intelligent Manufacturing System
    Independently developed full-servo intelligent production lines, significantly improving production efficiency while ensuring stable and reliable product quality.

4

Core
Strengths
Learn more
Global Supply Capability
Global Supply Capability
Global Supply Capability
  • Northeast

  • Hebei

  • Shanghai

  • Northwest

The company continues to advance its global production capacity layout, planning to build multi-regional production bases in China to create a stable and efficient plant-based capsule supply system.

Capacity Planning
It is planned to achieve an annual production capacity of 124 billion plant-based capsules by 2028.
The Northeast production cluster is planned for 40 billion capsules.
The Northwest production cluster consists of two bases, each planned for 40 billion capsules.

The Hebei demonstration base has already achieved an annual capacity of 4 billion capsules.

View Production Process
Certification
Certifications
Global Certifications · Quality Assurance
The company has established a comprehensive quality management system, and its products have obtained multiple internationally recognized certifications, meeting the quality and regulatory requirements of the global pharmaceutical and nutritional health industries.
View Certifications & Credentials
Product Brochure
Name*
Tel*
Company*
Email*
*Required field
contact us
Contact Us

Service Hotline

+86 021 6910 8726
  • Phone:+86 191 4559 1287
  • Email:info@unicorncapsule.com
  • Address:201-205, No. 4811, Cao 'an Road, Anting Town, Jiading District, Shanghai
  • Share:
Request a Sample
Copyright © Unicornshell Pharmaceutical Technology Co., Ltd. All Rights Reserved Powered by Raise